ESD and lung carcinoma: Our findings are significant because the small molecule FPD5 activates the ESD enzyme activity to inhibit the nuclear export of p53, thereby inhibiting the growth of lung cancer, opening up a new approach for future studies of this novel ESD-mediated signaling pathway (Figure 7).